Prof. Mingxin Yu 于明新
Chief Physician, Professor
Gynecology, Liaoning Cancer Hospital & Institute, Shenyang
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Standardized diagnosis and treatment of benign and malignant gynecologic tumors. Expertise in complex laparoscopic minimally invasive surgery, including fertility-sparing procedures for cervical cancer, radical surgery for advanced ovarian cancer, and individualized chemoradiotherapy.
Dr. Yu is a Chief Physician, Professor, and former Director of the Second Gynecology Ward at Liaoning Cancer Hospital & Institute. With 38 years of clinical experience, Dr. Yu specializes in standardized surgical and comprehensive treatment for gynecologic tumors, focusing on complex laparoscopic procedures and patient-centered care.
Professional roles
- Member, Gynecology Branch, Chinese Medical Association (Liaoning)
- Standing Committee Member, Gynecologic Oncology Branch, China Maternal and Child Health Care Association
- Chair, Gynecologic Minimally Invasive Therapy Professional Committee, Liaoning Society for Cell Biology
- Standing Committee Member, Gynecologic Laparoscopy Committee, Liaoning Anti-Cancer Association
Name order: in Chinese the family name comes first (Yu Mingxin). Papers usually list the name as Mingxin Yu or Yu M.
Selected publications
8 papers on PubMed matched by name and affiliation; 4 as first or senior author since 2016. Most recent first- or senior-author papers:
- Comput Math Methods Med, 2022 (senior author): Immune Subtype Profiling and Establishment of Prognostic Immune-Related lncRNA Pairs in Human Ovarian Cancer. PubMed 35578596
- Comput Math Methods Med, 2022 (senior author): Identification and Validation of Invasion-Related Molecular Subtypes and Prognostic Features for Cervical Cancer. PubMed 35345518
- DNA Cell Biol, 2020 (senior author): Identification of MMP1 as a Potential Prognostic Biomarker and Correlating with Immune Infiltrates in Cervical Squamous Cell Carcinoma. PubMed 31977248
- DNA Cell Biol, 2019 (senior author): Mechanism of Low Expression of miR-30a-5p on Epithelial-Mesenchymal Transition and Metastasis in Ovarian Cancer. PubMed 30839226
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion